The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 277-286

  Gotlieb, Neta ^a   Rosenne, Ella ^a   Matzner, Pini ^a   Shaashua, Lee ^a   Sorski, Liat ^a   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cortisol; Epinephrine; Ex vivo; Human; In vitro; In vivo; NK cytotoxicity; Prostaglandin; Stress; Whole blood

Indexed keywords

ADRENALIN; CATECHOLAMINE; HYDROCORTISONE; PROSTAGLANDIN E2; STRESS HORMONE; EPINEPHRINE;

ADULT; ARTICLE; BLOOD SAMPLING; CYTOTOXICITY; CYTOTOXICITY ASSAY; DRUG BLOOD LEVEL; DRUG EFFECT; EX VIVO STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LONG TERM EXPOSURE; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL LINE; IMMUNOLOGY; MENTAL STRESS; PLASMA;

CYTOTOXICITY, IMMUNOLOGIC; DINOPROSTONE; EPINEPHRINE; HUMANS; HYDROCORTISONE; IN VITRO TECHNIQUES; KILLER CELLS, NATURAL; PLASMA; STRESS, PSYCHOLOGICAL;

EID: 84924088379     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.12.020     Document Type: Article

References (63)

1. Andersen B.L., et al. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 1998, 90(1):30-36.
2. Baxevanis C.N., et al. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 1993, 72(2):491-501.
3. Baxevanis C.N., et al. Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin. Immunol. Immunopathol. 1994, 71(1):82-88.
4. Ben-Eliyahu S., et al. Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells. Br. J. Cancer 1996, 74(12):1900-1907.
5. Ben-Eliyahu S., et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 1999, 80(6):880-888.
6. Ben-Eliyahu S., et al. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 2000, 8(3):154-164.
7. Ben-Eliyahu S., Page G.G., Schleifer S.J. Stress, NK cells, and cancer: still a promissory note. Brain Behav. Immun. 2007, 21:881-887.
8. Benish M., et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 2008, 15(7):2042-2052.
9. Benish M., et al. The marginating-pulmonary immune compartment in mice exhibits increased NK cytotoxicity and unique cellular characteristics. Immunol. Res. 2014, 58(1):28-39.
10. Bodner G., Ho A., Kreek M.J. Effect of endogenous cortisol levels on natural killer cell activity in healthy humans. Brain Behav. Immun. 1998, 12(4):285-296.
11. Buvanendran A., et al. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 2006, 104(3):403-410.
12. Della Chiesa M., et al. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 2006, 108(12):3851-3858.
13. Cox W.I., Holbrook N.J., Friedman H. Mechanism of glucocorticoid action on murine natural killer cell activity. J. Natl. Cancer Inst. 1983, 71(5):973-981.
14. Dhabhar F.S. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann. N. Y. Acad. Sci. 2003, 992:205-217.
15. Dhabhar F.S., et al. Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain Behav. Immun. 2010, 24(1):127-137.
16. Felten S.Y., Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 1987, 18(1):37-48.
17. Felten D.L., et al. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985, 135(2 suppl.):755s-765s.
18. Fernandez N.C., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 1999, 5(4):405-411.
19. Gatti G., et al. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity. Immunopharmacology 1986, 11(2):119-128.
20. Glasner A., et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 2010, 184(5):2449-2457.
21. Greenfeld K., et al. Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav. Immun. 2007, 21(4):503-513.
22. Greisen J., et al. Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br. J. Anaesth. 1999, 83(2):235-240.
23. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allerg. Appl. Immunol. 1989, 89(4):334-341.
24. Inbar S., et al. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 2011, 6(4):e19246.
25. Kim R., et al. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 2006, 66(11):5527-5536.
26. Levi B., et al. Continuous stress disrupts immunostimulatory effects of IL-12. Brain Behav. Immun. 2011, 25(4):727-735.
27. Lewis J.G., Elder P.A. Intact or "active" corticosteroid-binding globulin (CBG) and total CBG in plasma: determination by parallel ELISAs using monoclonal antibodies. Clin. Chim. Acta 2012, 416:26-30.
28. Liedtke C.M. Differentiated properties of rabbit tracheal epithelial cells in primary culture. Am. J. Physiol. 1988, 255(6 Pt 1):C760-C770.
29. Lozzio B.B., Lozzio C.B. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk. Res. 1979, 3(6):363-370.
30. Marcenaro E., et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J. Immunol. 2005, 174(7):3992-3998.
31. Melamed R., et al. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 2005, 19(2):114-126.
32. Melamed R., et al. The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J. Immunother. 2010, 33(1):16-29.
33. Meron G., et al. PGE (2) suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav. Immun. 2013, 28:128-138.
34. Nguyen K.B., et al. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 2000, 1(1):70-76.
35. Nguyen K.B., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 2002, 169(8):4279-4287.
36. Ottenhof P.C., Morales A., Baines M.G. Quantitation of a whole blood assay for human natural killer cell activity. J. Immunol. Methods 1981, 42(3):305-318.
37. Pedersen B.K., et al. Modulation of natural killer cell activity in peripheral blood by physical exercise. Scand. J. Immunol. 1988, 27(6):673-678.
38. Pollock R.E., et al. Lytic units reconsidered: pitfalls in calculation and usage. J. Clin. Lab. Anal. 1990, 4:274-282.
39. Ree R.C., Platts A.A. A modified short-term cytotoxicity test: assessment of natural cell mediated cytotoxicity in whole blood. J. Immunol. Methods 1983, 62:79-83.
40. Rosenne E., et al. In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav. Immun. 2014, 37:207-219.
41. Sareneva T., Julkunen I., Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 2000, 165(4):1933-1938.
42. Schedlowski M., et al. Changes of natural killer cells during acute psychological stress. J. Clin. Immunol. 1993, 13(2):119-126.
43. Shaashua L., et al. Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids. Psychoneuroendocrinology 2014, 42:11-23.
44. Shakhar G., Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 1998, 160(7):3251-3258.
45. Shakhar K., et al. Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br. J. Cancer 2000, 83(12):1630-1636.
46. Shakhar K., et al. Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage. Fertil. Steril. 2003, 80(2):368-375.
47. Shakhar K., et al. High NK cell activity in recurrent miscarriage: what are we really measuring?. Hum. Reprod. 2006, 21(9):2421-2425.
48. Shakhar G., et al. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis. Ann. Surg. Oncol. 2007, 14(2):841-852.
49. Skibinski G., et al. Relative immunosuppressive activity of human seminal prostaglandins. J. Reprod. Immunol. 1992, 22(2):185-195.
50. Takamoto T.Y., et al. Norepinephrin inhibits human natural killer cell activity in vitro. Int. J. Neurosci. 1991, 58:127.
51. Tarr A.J., et al. Beta-adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav. Immun. 2012, 26(8):1226-1238.
52. Tonnesen E., Tonnesen J., Christensen N.J. Augmentation of cytotoxicity by natural killer (NK) cells after adrenaline administration in man. Acta Pathol. Microbiol. Immunol. Scand. C 1984, 92(1):81-83.
53. Tonnesen E., Christensen N.J., Brinklov M.M. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur. J. Clin. Invest. 1987, 17(6):497-503.
54. Torgersen K.M., et al. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J. Biol. Chem. 1997, 272(9):5495-5500.
55. Ueda F., et al. Adrenergic regulation of prostaglandin biosynthesis in cultured rabbit gastric epithelial cells. Jpn. J. Pharmacol. 1994, 65(2):113-120.
56. Vitoratos N., et al. Prostaglandin F1a and prostaglandin E2 plasma levels after transvaginal cervical cerclage. Clin. Exp. Obstet. Gynecol. 1996, 23(1):21-25.
57. Whalen M.M., Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem. J. 1990, 272(2):327-331.
58. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J. Immunother. 1997, 20(3):165-177.
59. Yakar I., et al. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 2003, 10(4):469-479.
60. Yirmiya R., et al. Ethanol increases tumor progression in rats: possible involvement of natural killer cells. Brain Behav. Immun. 1992, 6(1):74-86.
61. Yovel G., et al. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav. Immun. 2000, 14(3):153-169.
62. Yovel G., Shakhar K., Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol. Oncol. 2001, 81(2):254-262.
63. Zhou J., et al. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol. 1997, 178(2):108-116.